GOTTLIEB, A.; GISONDI, P.; EELLS, J.; PETERSON, L.; KAVANAUGH, A. Durability of Response in Patients with Psoriatic Arthritis Treated with Certolizumab Pegol over 216 Weeks: Post-Hoc Analyses from the RAPID-PsA Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 1, p. S2, 2020. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/801. Acesso em: 3 jul. 2024.